Cary Street Partners Investment Advisory’s Elanco Animal Health ELAN Stock Holding History

Cary Street Partners Investment Advisory’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$65.7K	Buy	2,669 +114	+4%	+$2.64K	0.01%	558
2026 Q1	$61.1K	Buy	2,555 +2,250	+738%	+$55K	0.02%	515
2025 Q4	$6.9K	Buy	305 +90	+42%	+$1.96K	﹤0.01%	632
2025 Q3	$4.33K	Buy	215 +48	+29%	+$804	﹤0.01%	565
2025 Q2	$2.38K	Buy	167 +30	+22%	+$351	﹤0.01%	564
2025 Q1	$1.44K	Buy	+137	New	+$1.55K	﹤0.01%	547
2023 Q4	–	Sell	-1,800	Closed	-$20.2K	–	940
2023 Q3	$20.2K	Buy	1,800 +1,255	+230%	+$14.6K	﹤0.01%	1120
2023 Q2	$5.48K	Hold	545	–	–	﹤0.01%	1390
2023 Q1	$5.12K	Sell	545 -50	-8%	-$590	﹤0.01%	1321
2022 Q4	$7.27K	Sell	595 -2,259	-79%	-$28.2K	﹤0.01%	1224
2022 Q3	$35K	Buy	2,854 +2,055	+257%	+$35.9K	﹤0.01%	496
2022 Q2	$16K	Buy	+799	New	+$18.9K	﹤0.01%	543
2021 Q3	–	Sell	-1,134	Closed	-$39K	–	264
2021 Q2	$39K	Hold	1,134	–	–	0.01%	295
2021 Q1	$33K	Buy	+1,134	New	+$34.9K	0.01%	281
2020 Q4	–	Sell	-35,660	Closed	-$996K	–	500
2020 Q3	$996K	Buy	+35,660	New	+$904K	0.21%	127

Other funds holding ELAN

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Cary Street Partners Investment Advisory's ELAN Position: Q2 2026 in Review

Cary Street Partners Investment Advisory increased its Elanco Animal Health (ELAN) stake by 4.5% in Q2 2026, buying an estimated $2.64K and bringing the position to 2,669 shares worth $65.7K. The position accounts for 0.01% of the portfolio, ranked #558.

Cary Street Partners Investment Advisory first reported a position in ELAN in Q3 2020 and has held it in 15 quarters since. The position peaked at $996K in Q3 2020. 523 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

Cary Street Partners Investment Advisory held 2,669 shares of Elanco Animal Health worth $65.7K as of Q2 2026.
Cary Street Partners Investment Advisory bought 114 Elanco Animal Health shares in Q2 2026, an estimated $2.64K.
Elanco Animal Health made up 0.01% of Cary Street Partners Investment Advisory's portfolio in Q2 2026, its #558 holding.
Cary Street Partners Investment Advisory first reported a position in Elanco Animal Health in Q3 2020 and has held it in 15 quarters since.
Cary Street Partners Investment Advisory's Elanco Animal Health position peaked at $996K in Q3 2020.
523 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Cary Street Partners Investment Advisory's 13F filing for Q2 2026, filed 17 Jul 2026.